Search Results - "Baldrich, E"

European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo by Pereira, M.P., Steinke, S., Zeidler, C., Forner, C., Riepe, C., Augustin, M., Bobko, S., Dalgard, F., Elberling, J., Garcovich, S., Gieler, U., Gonçalo, M., Halvorsen, J. A., Leslie, T.A., Metz, M., Reich, A., Şavk, E., Schneider, G., Serra‐Baldrich, E., Ständer, H.F., Streit, M., Wallengren, J., Weller, K., Wollenberg, A., Bruland, P., Soto‐Rey, I., Storck, M., Dugas, M., Weisshaar, E., Szepietowski, J.C., Legat, F.J., Ständer, S.

“…Background The term prurigo has been used for many decades in dermatology without clear definition, and currently used terminology of prurigo is inconsistent…”
Get full text

Detection of uric acid at reversibly nanostructured thin-film microelectrodes by Herrasti, Z., Martínez, F., Baldrich, E.

“…Nanomaterials such as carbon nanotubes (CNT) are extensively used to produce electrodes of enhanced performance. However, since their incorporation tends to be…”
Get full text

Omalizumab for the treatment of chronic inducible urticaria in 80 patients by Exposito‐Serrano, V., Curto‐Barredo, L., Aguilera Peiro, P., Gómez Armayones, S., Serra‐Baldrich, E., Spertino, J., Bonfill Ortí, M., Figueras Nart, I., Melé‐Ninot, G., Baliu‐Piqué, C., Sala Cunill, A., Labrador‐Horrillo, M., Guilabert Vidal, A., Fernández Chico, N., Giménez‐Arnau, A.M.

Get full text

Chronic nodular prurigo: clinical profile and burden. A European cross‐sectional study by Pereira, M.P., Hoffmann, V., Weisshaar, E., Wallengren, J., Halvorsen, J.A., Garcovich, S., Misery, L., Brenaut, E., Savk, E., Potekaev, N., Lvov, A., Bobko, S., Szepietowski, J.C., Reich, A., Bozek, A., Legat, F.J., Metz, M., Streit, M., Serra‐Baldrich, E., Gonçalo, M., Storck, M., Greiwe, I., Nau, T., Steinke, S., Dugas, M., Ständer, S., Zeidler, C., Dalgard, F., Elberling, J., Forner, C., Leslie, T., Riepe, C., Schneider, G., Ständer, H.

“…Background Chronic nodular prurigo (CNPG) is a condition characterized by chronic itch, a prolonged scratching behaviour and the presence of pruriginous…”
Get full text

Pathophysiology and management of sensitive skin: position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI) by Misery, L., Weisshaar, E., Brenaut, E., Evers, A.W.M., Huet, F., Ständer, S., Reich, A., Berardesca, E., Serra‐Baldrich, E., Wallengren, J., Linder, D., Fluhr, J.W., Szepietowski, J.C., Maibach, H., Honari, Golara, Le Gall‐Ianotto, Christelle, Takamori, Kenji, Richters, Renée

“…The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the…”
Get full text

Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series by Armario‐Hita, J.C., Pereyra‐Rodriguez, J., Silvestre, J.F., Ruiz‐Villaverde, R., Valero, A., Izu‐Belloso, R., Jáuregui‐Presa, I., Curto‐Barredo, L., Figueras‐Nart, I., Herranz‐Pinto, P., Herraez‐Herrera, L., Ortiz‐de‐Frutos, F.J., Martinez‐Pilar, L., Sastre, J., Serra‐Baldrich, E.

Get full text

Position statement: topical calcineurin inhibitors in atopic dermatitis by Remitz, A., De Pità, O., Mota, A., Serra‐Baldrich, E., Vakirlis, E., Kapp, A.

“…Background Atopic dermatitis (AD) is a common inflammatory skin disease in both adults and children. Whilst topical calcineurin inhibitors (TCIs), tacrolimus…”
Get full text

Effect of agitation in magneto-assay performance by Ruiz-Vega, G., Baldrich, E.

“…•MPO binding at magnetic beads is faster and more sensitive than ELISA.•MP mixing conditions have significant effect on magneto-immunobinding…”
Get full text

An internet of things-based intensity and time-resolved fluorescence reader for point-of-care testing by Alonso, O., Franch, N., Canals, J., Arias-Alpízar, K., de la Serna, E., Baldrich, E., Diéguez, A.

“…A miniature internet of things (IoT)-based point-of-care testing (PoCT) fluorescence reader, able to perform both intensity and time-resolved measurements of…”
Get full text

Cross‐European validation of the ItchyQoL in pruritic dermatoses by Zeidler, C., Steinke, S., Riepe, C., Bruland, P., Soto‐Rey, I., Storck, M., Garcovich, S., Blome, C., Bobko, S., Legat, F.J., Potekaev, N., Lvov, A., Misery, L., Weger, W., Reich, A., Şavk, E., Streit, M., Serra‐Baldrich, E., Szepietowski, J.C., Yosipovitch, G., Chen, S.C., Dugas, M., Ständer, S.

“…Background Chronic pruritus (CP) is a frequently occurring symptom in inflammatory dermatoses, causing a high burden and limitations to health‐related quality…”
Get full text

Drug survival of systemic and biological treatments for moderate‐to‐severe atopic dermatitis in adults: a multicentre retrospective observational study by Pereyra‐Rodriguez, J.J., Domínguez‐Cruz, J., Ruiz‐Villaverde, R., Silvestre, J.F., Galán, M., Curto, L., Figueras, I., Serra‐Baldrich, E., Armario‐Hita, J.C.

Get full text

Pruritus Intensity Scales across Europe: a prospective validation study by Storck, M., Sandmann, S., Bruland, P., Pereira, M.P., Steinke, S., Riepe, C., Soto‐Rey, I., Garcovich, S., Augustin, M., Blome, C., Bobko, S., Legat, F.J., Potekaev, N., Lvov, A., Misery, L., Weger, W., Reich, A., Şavk, E., Streit, M., Serra‐Baldrich, E., Szepietowski, J.C., Dugas, M., Ständer, S., Zeidler, C.

“…Background Chronic pruritus (CP) is a subjective symptom, and it is necessary to assess its intensity with validated patient‐reported outcome tools in order to…”
Get full text

Chronic nodular prurigo: Association between comorbidities, itch and quality of life by Pereira, M. P., Gutsche, A., Weisshaar, E., Halvorsen, J. A., Wallengren, J., Legat, F. J., Garcovich, S., Savk, E., Reich, A., Bozek, A., Lvov, A., Bobko, S., Metz, M., Streit, M., Misery, L., Brenaut, E., Serra‐Baldrich, E., Goncalo, M., Szepietowski, J. C., Augustin, M., Zeidler, C., Ständer, S.

Get full text

Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis by Serra-Baldrich, E, Santamaría-Babí, L F, Francisco Silvestre, J

Get full text

Malaria quantitative POC testing using magnetic particles, a paper microfluidic device and a hand-held fluorescence reader by Arias-Alpízar, K., Sánchez-Cano, A., Prat-Trunas, J., de la Serna Serna, E., Alonso, O., Sulleiro, E., Sánchez-Montalvá, A., Diéguez, A., Baldrich, E.

“…A point-of-care (POC) device is reported for highly sensitive and selective detection of Plasmodium falciparum lactate dehydrogenase (Pf-LDH), a biomarker of…”
Get full text

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria by Curto‐Barredo, L., Spertino, J., Figueras‐Nart, I., Expósito‐Serrano, V., Guilabert, A., Melé‐Ninot, G., Cubiró, X., Bonfill‐Ortí, M., Garcias‐Ladaria, J., Villar, M., García‐Navarro, X., Bielsa‐Marsol, I., Vilavella, M., Aparicio, G., Baliu‐Piqué, C., Álvarez, A., Lamas‐Domenech, N., Duran‐Jordà, X., Serra‐Baldrich, E., Giménez‐Arnau, A.

Get full text

First update of the living European guideline (EuroGuiDerm) on atopic eczema by Wollenberg, A, Kinberger, M, Arents, B, Aszodi, N, Barbarot, S, Bieber, T, Brough, H A, Pinton, P C, Christen-Zaech, S, Deleuran, M, Dittmann, M, Fosse, N, Gáspár, K, Gerbens, L A A, Gieler, U, Girolomoni, G, Gregoriou, S, Mortz, C G, Nast, A, Nygaard, U, Rehbinder, E M, Ring, J, Rossi, M, Roxburgh, C, Serra-Baldrich, E, Simon, D, Szalai, Z Z, Szepietowski, J C, Torrelo, A, Werfel, T, Flohr, C

Get full text

Assessing the value of moderate‐to‐severe atopic dermatitis treatment using multi‐criteria decision analysis (MCDA) by Pereyra‐Rodríguez, J. J., Poveda, J. L., Rivero, A., Serra‐Baldrich, E., Silvestre, J. F., Armario‐Hita, J. C., Calleja, M. Á., Carrascosa, J. M., Flórez, Á., Herranz, P., Comellas, M., Ortiz de Frutos, F. J.

Get full text